Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-18

Clinical Trial Update: Drug Survival of Target Therapies in Atopic Dermatitis

View source ↗

Summary

A clinical trial is currently recruiting to assess drug survival (durability of use) of targeted therapies in atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Atopic Dermatitis | Status: RECRUITING